Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNZ101 for the Treatment of Presbyopia
NCT05656027Phase 3Completed
- Sponsor
- LENZ Therapeutics
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aceclidine, brimonidine tartrate + sodium hyaluronate in presbyopia, sponsored by LENZ Therapeutics. Started Dec 2022; status: completed.
02
Drugs
aceclidinebrimonidine tartrate + sodium hyaluronate
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05656027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05656027.